Related Experiment Videos
Infective endocarditis: too ill to be operated?
Bina Rubinovitch1, Didier Pittet
1Director of Infection Control Program, Department of Internal Medicine, University of Geneva Hospitals, Switzerland. didier.pittet@hcuge.ch
Insights
Infective endocarditis treatment combining medical and surgical approaches improves survival in complicated cases, particularly those with heart failure. Clinical judgment remains crucial for complex neurological or multi-organ failure scenarios.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Infective endocarditis presents significant mortality risks, primarily due to neurological complications and congestive heart failure.
- Valvular dysfunction secondary to heart failure is a key factor in patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of combined medical and surgical therapy in complicated infective endocarditis.
- To identify consensus indications for surgical intervention in specific patient subgroups.
Main Methods:
- Review of existing data on combined medical and surgical treatment for infective endocarditis.
- Analysis of outcomes in patients with valvular dysfunction, neurological complications, and multiple organ failure.
- Assessment of surgical feasibility and risk in intensive care unit settings.
Main Results:
- Combined therapy reduces mortality in complicated infective endocarditis, especially when heart failure is present.
- Heart failure is the primary driver for valve replacement decisions.
- Surgical intervention is feasible in intensive care unit patients with acceptable in-hospital mortality, despite neurological or multi-organ failure.
Conclusions:
- Combined medical and surgical therapy offers improved outcomes for infective endocarditis patients with heart failure.
- Clear surgical indications are lacking for neurological complications or multiple organ failure.
- Multicenter studies with robust scoring systems are needed to refine treatment strategies for critically ill patients.
Abstract:
Infective endocarditis remains a disease associated with high mortality in certain groups of patients, with death resulting primarily from central nervous system complications and congestive heart failure. Combined medical and surgical therapy reduces both early and late mortality in complicated cases, especially in patients with valvular dysfunction related to heart failure. In these patients, heart failure is the strongest indication for valve replacement. There are no consensus indications for surgery, however, in the presence of neurological complications or multiple organ failure. Limited data suggest that such surgery is feasible, even in complicated cases necessitating admission to the intensive care unit, and carries an acceptable risk for in-hospital mortality. It is important that critically ill patients with infective endocarditis are enrolled into multicenter studies, using adequate severity scoring systems to assess the impact of clinical and imaging variables on patients' outcome. Until such data are obtained, clinical judgement is still the best tool in decision-making regarding the individual patient.